Heidelberg Pharma competitive analysis

Explore patent oppositions filed by Heidelberg Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Bcma-Based Stratification And Therapy For Multiple Myeloma PatientsBOEHRINGER INGELHEIMApr 27, 2017
Psma AntibodiesPSMAJul 14, 2016

Latest PTAB cases involving Heidelberg Pharma

Discover the latest PTAB cases involving Heidelberg Pharma, highlighting their recent legal challenges and patent disputes.